(Q34497398)

2 August 2017

1 reference

title

Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention (English)

1 reference

2 August 2017

1 reference

1 reference

Fabian CJ

1

1 reference

2 August 2017

Kimler BF

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Annals of the New York Academy of Sciences

2 August 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 August 2017

volume

952

1 reference

2 August 2017

page(s)

44-59

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Transforming growth factor alpha in epithelial proliferative diseases of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Determinants of tissue estradiol levels and biologic responsiveness in breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Demonstration of aromatase activity and its regulation in breast tumor and benign breast fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Regulation of estrogen receptor-alpha gene expression by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Cathepsin D and epidermal growth factor in human breast cyst fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Selective estrogen receptor modulators: structure, function, and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Lessons from the use of aromatase inhibitors in the neoadjuvant setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Matrix metalloproteinases: biologic activity and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB02727.X

10.1111/J.1749-6632.2001.TB02727.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference